Luigi Mangione, 26, has been indicted on federal charges in connection with the December 2024 murder of UnitedHealthcare CEO Brian Thompson. The indictment, handed down by a federal grand jury, includes one count of murder with a firearm, another firearms offense, and two counts of stalking. This development comes after Attorney General Pam Bondi instructed federal prosecutors to seek the death penalty. Mangione’s attorneys have already filed motions to remove this option.
The shooting occurred outside a Manhattan hotel on December 4th, 2024, where Thompson was attending an investor meeting. Following a nationwide manhunt, Mangione was apprehended in Pennsylvania on December 9th. He has pleaded not guilty to the federal charges, as well as to state murder charges in New York and additional charges in Pennsylvania.
Authorities allege that Mangione meticulously planned the murder, traveling to New York City in late November under a false identity and staying in a hostel. Evidence suggests he meticulously planned the attack, and the words “delay,” “deny,” and possibly “depose” were found written on shell casings at the crime scene. Despite the extensive investigation, a clear motive remains elusive, with investigators confirming Mangione was not a UnitedHealthcare customer.
Further investigation revealed Mangione possessed a 3D-printed ghost gun with a suppressor, believed to be the murder weapon, upon his arrest. This detail underscores the seriousness and premeditation involved in the crime.
The case has drawn significant attention due to the high-profile victim and the potential for the death penalty. Mangione’s legal team is actively working to challenge the charges and the pursuit of capital punishment. This case continues to unfold with significant implications for both the Mangione family and the broader legal landscape surrounding gun violence and cross-state crimes.
This story is developing and will be updated as more information becomes available. Check back for further details.
